Pei, Xin-Yan <br/><br/>
MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.  [electronic resource] 

 -  Blood  Sep 2007 
 - 2092-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-04-083204  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--antagonists & inhibitors<br/>Bcl-2-Like Protein 11<br/>Benzamides--pharmacology<br/>Blotting, Western<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Immunoprecipitation<br/>Insulin-Like Growth Factor I--pharmacology<br/>Interleukin-6--pharmacology<br/>MAP Kinase Kinase 1--antagonists & inhibitors<br/>MAP Kinase Kinase 2--antagonists & inhibitors<br/>Membrane Proteins--antagonists & inhibitors<br/>Multiple Myeloma--drug therapy<br/>Phosphorylation--drug effects<br/>Protein Conformation<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Transport<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>RNA, Small Interfering--pharmacology<br/>Staurosporine--analogs & derivatives<br/>Subcellular Fractions<br/>bcl-2 Homologous Antagonist-Killer Protein--metabolism<br/>bcl-2-Associated X Protein--metabolism<br/>bcl-X Protein--metabolism